In This Section
Investor Relations
Get stock updates, FAQs, and more.
Our Best-in-Class Companies
Find a powerful partner that promises results.
Contact Information
If you are representing a media outlet and have immediate questions, please contact:
MARCIA FREDERICK
614.543.6281
mfrederick@inventivhealth.com
Press Releases
Bob Chandler, Chandler Chicco Co-Founder, Receives SABRE Award for Outstanding Individual Achievement
May 13, 2010 - Somerset, NJ - Bob Chandler, principal and co-founder of the Chandler Chicco Companies, part of inVentiv Health [NASDAQ: VTIV], received a SABRE Award for Individual Achievement at Tuesday evening’s 2010 U.S. SABRE Awards ceremony, hosted by The Holmes Group.
Chandler received the award, which honors the exceptional work of public relations professionals, in recognition of his “bold vision [for a firm] built on strong values and a people-first approach,” and his leadership of “some of the most significant healthcare communications campaigns of recent years.” Chandler is one of three award recipients this year, who also include Jon Iwata, IBM’s Senior Vice President, Marketing and Communications, and Carol Cone, founder of Cone LLC, one of the top corporate responsibility communication agencies in the country.
“It is truly an honor to be the recipient of this award, especially as Chandler Chicco celebrates our 15th anniversary this year,” said Chandler. “I want to share this award with the incredibly talented and dedicated people I’ve been proud to call colleagues, clients and friends along this journey, and who continue to inspire me every day.”
Chandler and his long-time business partner Gianfranco Chicco founded the Chandler Chicco Agency in 1995, and today it is the world’s leading healthcare public relations firm, employing more than 300 people across offices in New York, London, Los Angeles, Washington and Paris. Chandler Chicco was named “Healthcare Agency of the Decade” by The Holmes Report in January 2010 – a decade in which Chandler Chicco quadrupled in size, expanded into European markets, developed design, research and advertising capability, and became part of healthcare services company inVentiv Health in 2007. The agency currently offers public relations and communications counsel to a list of over 40 clients, including hospitals, NGOs, healthcare associations, coalitions, and many of the world’s largest pharmaceutical companies.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: our ability to sufficiently increase our revenues and maintain or decrease expenses and cash capital expenditures to permit us to fund our operations; our ability to continue to comply with the covenants and terms of our credit facility and to access sufficient capital to fund our operations; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; our ability to successfully operate new lines of business; our ability to manage our infrastructure and resources to support our growth; our ability to successfully identify new businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses into our operations; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our clients base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the actual impact of the adoption of certain accounting standards; our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing; and our inability to determine the actual time at which the liquidation of the Columbia Strategic Cash Portfolio will be completed or the total losses that we will actually realize from that investment vehicle. . Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
